Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥300.00 JPY
Change Today 0.00 / 0.00%
Volume 28.0K
As of 2:00 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

jms co ltd (7702) Snapshot

Open
¥297.00
Previous Close
¥300.00
Day High
¥301.00
Day Low
¥297.00
52 Week High
10/16/14 - ¥309.00
52 Week Low
05/21/14 - ¥280.00
Market Cap
14.8B
Average Volume 10 Days
26.4K
EPS TTM
¥-1.60
Shares Outstanding
49.5M
EX-Date
03/27/15
P/E TM
--
Dividend
¥8.00
Dividend Yield
2.67%
Current Stock Chart for JMS CO LTD (7702)

Related News

No related news articles were found.

jms co ltd (7702) Related Businessweek News

No Related Businessweek News Found

jms co ltd (7702) Details

JMS Co., Ltd. manufactures, sells, exports, and imports medical equipment and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion pumps, syringe pumps, and semisolid nutrition feeding devices for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon’s gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, safety AV fistula needles, AV fistula needles, hemodialysis blood tubing sets, dialyzer, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipments, membrane oxygenator, heat exchangers, pacemakers, micro catheters, and cardiopulmonary blood tubing sets. JMS Co., Ltd. was founded in 1965 and is headquartered in Hiroshima, Japan.

7,144 Employees
Last Reported Date: 06/26/14
Founded in 1965

jms co ltd (7702) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jms co ltd (7702) Key Developments

JMS Co., Ltd. Announces Consolidated Earnings Results for Nine Months Ended December 31, 2014 ; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015 ; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2015

JMS Co., Ltd. announced consolidated earnings results for nine months ended December 31, 2014. For the period, the company reported net sales of ¥41,046 million, operating income of ¥401 million, ordinary income of ¥493 million, income before income taxes and minority interests of ¥860 million, net income of ¥294 million or ¥6.05 per share compared to the net sales of ¥39,840 million, operating income of ¥600 million, ordinary income of ¥916 million, income before income taxes and minority interests of ¥554 million, net income of ¥580 million or ¥11.89 per share for the same period a year ago. For the year ending March 31, 2015, the company expected net sales of ¥55,000 million, operating income of ¥700 million, ordinary income of ¥800 million, net income of ¥450 million and earnings per share of ¥9.23. For the year ending March 31, 2015, the company expected year end dividend of ¥4.00 per share compared to the same dividend paid in the previous year.

JMS Co., Ltd. to Report Q3, 2015 Results on Feb 05, 2015

JMS Co., Ltd. announced that they will report Q3, 2015 results on Feb 05, 2015

JMS Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2014; Revises Earnings Guidance for the Fiscal Year Ending March 31, 2015; Declares Dividend for the Second Quarter Ended September 30, 2014, Payable on December 10, 2014; Provides Dividend Guidance for the Full Year Ending March 31, 2015

JMS Co. Ltd. announced consolidated earnings results for the six months ended September 30, 2014. For the period, the company reported net sales of ¥26,249 million against ¥25,714 million a year ago. Operating income was ¥46 million against ¥196 million a year ago. Ordinary income was ¥143 million compared to ¥444 million in the same period last year. Net income was ¥72 million or ¥1.49 per share against ¥200 million or ¥4.12 per share a year ago. Income before income taxes and minority interests was ¥292 million against ¥398 million a year ago. Income before minority interests was ¥204 million against ¥83 million a year ago. Net cash provided by operating activities was ¥1,149 million against ¥647 million a year ago. Purchase of property, plant and equipment was ¥1,156 million against ¥2,456 million a year ago. Purchase of intangible assets was ¥49 million against ¥108 million a year ago. For the fiscal year ending March 31, 2015, the company expects net sales of ¥55,000 million, operating income of ¥700 million, ordinary income of ¥800 million and net income of ¥450 million or ¥9.23 per share against previous forecast of net sales of ¥56,000 million, operating income of ¥1,200 million, ordinary income of ¥1,400 million and net income of ¥800 million. For the second quarter ended September 30, 2014, the company declared dividend of ¥4.00 per share, payable on December 10, 2014 against ¥4.00 per share in 2013. For the full year ending March 31, 2015, the company expects to pay dividend of ¥4.00 per share against ¥4.00 per share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7702:JP ¥300.00 JPY 0.00

7702 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $70.17 USD -0.19
Fresenius Medical Care AG & Co KGaA €80.17 EUR +0.76
Nipro Corp ¥1,174 JPY +8.00
NxStage Medical Inc $18.86 USD +0.51
View Industry Companies
 

Industry Analysis

7702

Industry Average

Valuation 7702 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow 45.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JMS CO LTD, please visit www.jms.cc. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.